Cardio Diagnostics Holdings Inc. Warrant (CDIOW)

About CDIOW

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable C…

Sector

Health Care

Industry

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Employees

15

Fundamentals

1-day range

$0.0064$0.0087

Market cap

$50.3K

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

—

Dividend yield

—

Beta

1.47

Avg. volume

—

Cardio Diagnostics Holdings Inc. Warrant Competitors

Chosen by industry and closest market cap.

• CDIOW

  Cardio Diagnostics Holdings Inc. Warrant

  $0.0064

  ▼ 28.09%
  Market cap $50.3KP/E —
  $0.0052$0.0721
• VRAX

  Virax Biolabs Group Limited Ordinary Shares

  $1.45

  ▼ 10.49%
  Market cap $2.21MP/E —
  $1.55$21.75
• CDIO

  Cardio Diagnostics Holdings Inc. Common stock

  $1.69

  ▼ 3.98%
  Market cap $4.91MP/E —
  $0.97$7.91
• BMRA

  Biomerica Inc. Common Stock

  $1.85

  ▼ 1.60%
  Market cap $4.94MP/E —
  $1.45$3.21
• TRIB

  Trinity Biotech plc American Depositary Shares

  $8.03

  ▲ 1.26%
  Market cap $7.86MP/E —
  $5.01$52.5
• VNRX

  VolitionRX Limited Common Stock

  $0.18

  ▼ 5.26%
  Market cap $9.23MP/E —
  $0.18$10.31
• QCLS

  Q/C Technologies Inc. Common Stock

  $0.538

  ▼ 3.58%
  Market cap $21.99MP/E —
  $0.4201$8.17

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Cardio Diagnostics Holdings, Inc. (CDIO) Shareholder/Analyst Call Prepared Remarks Transcript
  SeekingAlpha · 9/18/2026

Institutional Ownership

March 31, 2026

Total shares held

535.4K

Total value held

$125.1K

Institutional holders

7